Re: NEWS - Draft NICE guidance does not recommend Orencia (abatacept) for second-line use in RA

[Guest guest]

What does it mean to " open a draft guidance " ? I was on Remicade for years but it

stopped working. Now I have started Orencia (new) and methotrexate (after

almost a year) again.

Thank you

Maggie

>

> Draft NICE Guidance Does Not Recommend Abatacept For Second-Line Use

> In Rheumatoid Arthritis

>

>

> MedicalNewsToday.com

> Article Date: 30 Mar 2011 - 3:00 PDT

>

>

> The National Institute for Health and Clinical Excellence (NICE) has

> today (30 March 2011) opened a consultation on draft guidance which

> does not recommend abatacept (Orencia, Bristol-Myers Squibb), in

> combination with methotrexate, for the treatment of moderate to severe

> active rheumatoid arthritis in adults whose disease has responded

> inadequately to one or more conventional non-biological disease

> modifying anti-rheumatic drugs (DMARDs) including methotrexate.

>

> ***************************************

> Read the full article here:

>

> http://www.medicalnewstoday.com/articles/220641.php

>

>

>

> Not an MD

>

[Guest guest]

Hello, Maggie.

The National Institute for Health and Clinical Excellence (NICE) is a

UK organization which makes recommendations and creates guidelines for

the National Health Service (NHS - UK).

That they've " opened a consultation on draft guidance " means that they

are announcing that they are examining a particular issue, but that

the final guideline hasn't been decided yet. They then receive input

on what they are proposing.

http://www.nice.org.uk/

In this case, they have stated that they believe that Orencia

(abatacept) is not a cost-effective option for those with RA who have

failed non-biologic DMARDs.

Not an MD

On Sat, Apr 2, 2011 at 10:01 AM, maggiemac52 <maggiemac52@...> wrote:

> What does it mean to " open a draft guidance " ? I was on Remicade for years but

it stopped working. Now I have started Orencia (new)  and methotrexate (after

almost a year) again.

> Thank you

> Maggie

[Guest guest]

Thanks so much !

Maggie

>

> Hello, Maggie.

>

> The National Institute for Health and Clinical Excellence (NICE) is a

> UK organization which makes recommendations and creates guidelines for

> the National Health Service (NHS - UK).

>

> That they've " opened a consultation on draft guidance " means that they

> are announcing that they are examining a particular issue, but that

> the final guideline hasn't been decided yet. They then receive input

> on what they are proposing.

>

> http://www.nice.org.uk/

>

> In this case, they have stated that they believe that Orencia

> (abatacept) is not a cost-effective option for those with RA who have

> failed non-biologic DMARDs.

>

>

>

> Not an MD

>